Ola Engkvist

Ola Engkvist, PhD, is Executive Director and Head of Molecular AI within Discovery Sciences at AstraZeneca R&D, where he leads the development and application of machine learning and artificial intelligence to accelerate drug design. He has published over 180 peer-reviewed scientific articles and is an ELLIS fellow at the European Laboratory for Learning and Intelligent Systems and a 2025 Clarivate Highly Cited Researcher. He holds an adjunct professorship in machine learning and AI for drug design at Chalmers University of Technology, serves as a Trustee of the Cambridge Crystallographic Data Centre, and is recognized for his work in pharmaceutical innovation.